3.22 -0.01 (-0.31%) | 12-01 15:59 | |||||||||||||
|
|
Short term | ![]() ![]() ![]() |
|||
Mid term | ![]() ![]() ![]() |
|||
Targets | 6-month : | 4.21 | 1-year : | 4.66 |
Resists | First : | 3.6 | Second : | 3.99 |
Pivot price | 3.39 ![]() |
|||
Supports | First : | 2.99 | Second : | 2.48 |
MAs | MA(5) : | 3.15 ![]() |
MA(20) : | 3.47 ![]() |
MA(100) : | 3.16 ![]() |
MA(250) : | 3.54 ![]() |
|
MACD | MACD : | -0.1 ![]() |
Signal : | -0.1 ![]() |
%K %D | K(14,3) : | 20.9 ![]() |
D(3) : | 12.3 ![]() |
RSI | RSI(14): 47.1 ![]() |
|||
52-week | High : | 9.01 | Low : | 1.86 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ BNTC ] has closed above bottom band by 37.7%. Bollinger Bands are 3.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 3.47 - 3.49 | 3.49 - 3.5 |
Low: | 3.02 - 3.04 | 3.04 - 3.06 |
Close: | 3.15 - 3.18 | 3.18 - 3.21 |
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.
Thu, 30 Nov 2023
Benitec Biopharma Announces First Subject Dosed in Phase 1b/2a ... - BioSpace
Thu, 30 Nov 2023
Here's Why Benitec Biopharma Inc.'s (NASDAQ:BNTC) CEO ... - Yahoo Finance
Fri, 17 Nov 2023
2023-11-17 | NDAQ:BNTC | Press Release | Benitec Biopharma Inc - Stockhouse Publishing
Mon, 13 Nov 2023
Benitec Biopharma Releases First Quarter 2024 Financial Results ... - Yahoo Finance
Fri, 18 Aug 2023
JANUS HENDERSON GROUP PLC Acquires New Stake in Benitec ... - Yahoo Finance
Tue, 08 Aug 2023
Benitec Biopharma Inc. Announces Pricing of $30 Million ... - Yahoo Finance
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
NASDAQ
|
|
Sector:
Healthcare
|
|
Industry:
Biotechnology
|
|
Shares Out | 0 (M) |
Shares Float | 3 (M) |
Held by Insiders | 2e+006 (%) |
Held by Institutions | 0 (%) |
Shares Short | 68 (K) |
Shares Short P.Month | 0 (K) |
EPS | -2.026e+007 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | -27 % |
Return on Assets (ttm) | 166.6 % |
Return on Equity (ttm) | -56.4 % |
Qtrly Rev. Growth | 75000 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | -112.89 |
EBITDA (p.s.) | 76530.6 |
Qtrly Earnings Growth | -234.9 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | -19 (M) |
PE Ratio | -0.01 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | -0.03 |
Price to Cash Flow | 0.36 |
Dividend | 0 |
Forward Dividend | 46510 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |